Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Other Operating Expenses: 2022-2023

Historic Other Operating Expenses for Immuneering (IMRX) over the last 2 years, with Dec 2023 value amounting to $7,317.

  • Immuneering's Other Operating Expenses rose 0.01% to $7,317 in Q4 2023 from the same period last year, while for Dec 2023 it was $29,268, marking a year-over-year decrease of 2.61%. This contributed to the annual value of $29,267 for FY2023, which is 2.62% down from last year.
  • Latest data reveals that Immuneering reported Other Operating Expenses of $7,317 as of Q4 2023, which was down 0.00% from $7,317 recorded in Q3 2023.
  • In the past 5 years, Immuneering's Other Operating Expenses registered a high of $8,103 during Q1 2022, and its lowest value of $7,316 during Q4 2022.
  • Moreover, its 2-year median value for Other Operating Expenses was $7,317 (2023), whereas its average is $7,415.
  • The largest annual percentage gain for Immuneering's Other Operating Expenses in the last 5 years was 0.01% (2023), contrasted with its biggest fall of 9.70% (2023).
  • Over the past 2 years, Immuneering's Other Operating Expenses (Quarterly) stood at $7,316 in 2022, then climbed by 0.01% to $7,317 in 2023.
  • Its Other Operating Expenses stands at $7,317 for Q4 2023, versus $7,317 for Q3 2023 and $7,317 for Q2 2023.